InvestorsHub Logo
Followers 171
Posts 22524
Boards Moderated 0
Alias Born 11/01/2012

Re: None

Friday, 09/15/2023 8:29:07 AM

Friday, September 15, 2023 8:29:07 AM

Post# of 3504

On September 14, 2023, Moleculin Biotech, Inc. (the “Company”), issued a press release which announced its abstract has been accepted for poster presentation at the 2023 CTOS Annual Meeting being held November 1-4, 2023 in Dublin, Ireland
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MBRX News